{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:51:43Z","timestamp":1781830303155,"version":"3.54.5"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000090","name":"Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["PC210168 and PC23067, HEROIC PCaPH Africa1K"],"award-info":[{"award-number":["PC210168 and PC23067, HEROIC PCaPH Africa1K"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000090","name":"Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["PC200390 (TARGET Africa)"],"award-info":[{"award-number":["PC200390 (TARGET Africa)"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000892","name":"Prostate Cancer Foundation","doi-asserted-by":"publisher","award":["2023CHAL4150"],"award-info":[{"award-number":["2023CHAL4150"]}],"id":[{"id":"10.13039\/100000892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000892","name":"Prostate Cancer Foundation","doi-asserted-by":"publisher","award":["23CHAL18"],"award-info":[{"award-number":["23CHAL18"]}],"id":[{"id":"10.13039\/100000892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2024\/GNT2037298"],"award-info":[{"award-number":["2024\/GNT2037298"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2018\/GNT1165762"],"award-info":[{"award-number":["2018\/GNT1165762"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["1R01CA285772-01"],"award-info":[{"award-number":["1R01CA285772-01"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002337","name":"Petre Foundation","doi-asserted-by":"publisher","award":["Petre Chair (Hayes)"],"award-info":[{"award-number":["Petre Chair (Hayes)"]}],"id":[{"id":"10.13039\/501100002337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genome Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Kataegis, the focal hypermutation of single base positions in tumour genomes, has received little attention with regards to prostate cancer (PCa) molecular features, tumour evolution and associated clinical presentation. Most notably, the impact of this phenomenon is yet to be explored across ancestral lineages representing the extremities of PCa presentation and outcomes, with men of African ancestry disproportionately disadvantaged. The purpose of this study is to address the knowledge gap through African inclusive multi-ancestral interrogation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We assessed for ancestrally shared and unique molecular, evolutionary and clinical features of kataegis in 669 multi-ancestral whole PCa genomes. Access to raw whole-genome sequenced data allowed for direct single-pipeline comparative analysis between 109 southern African and 57 European derived treatment na\u00efve high-risk-biased primary tumours (74% and 88%) with paired blood samples, further assessed against publicly available 207 Asian high-risk-leaning comparative (65%) and 296 European low-risk-biased alternative (79%) resources. Comparisons between ancestries and risk groups were through Wilcoxon\u2019s rank sum test and Fisher\u2019s exact tests, with\n                      <jats:italic>P<\/jats:italic>\n                      values adjusted by false discovery rate.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Confirming relatively low burdens, we found kataegis to be significantly associated with genomic instability, cancer drivers, and clinical adversity across ancestries (false discovery rate =\n                      <jats:inline-formula>\n                        <jats:tex-math>$$\\:7.44\\times\\:{10}^{-6}-0.04$$<\/jats:tex-math>\n                      <\/jats:inline-formula>\n                      ). Notably, kataegis-postive tumours were associated with elevated prostate-specific antigen levels at presentation in African (false discovery rate =\n                      <jats:inline-formula>\n                        <jats:tex-math>$$\\:1.66\\times\\:{10}^{-3}$$<\/jats:tex-math>\n                      <\/jats:inline-formula>\n                      ) and higher risk for metastatic progression in European patients (Kaplan-Meier estimator,\n                      <jats:inline-formula>\n                        <jats:tex-math>$$\\:P=0.03$$<\/jats:tex-math>\n                      <\/jats:inline-formula>\n                      ). Enrichment of APOBEC\u2019s context preferences showed more attribution from APOBEC3B than APOBEC3A. Further through analyses of evolution and structural variant (SV) co-occurrence, commonly the ancestry agnostic SV-associated kataegis predominated in the clonal evolutionary state, while the less common the SV-independent kataegis (\n                      <jats:inline-formula>\n                        <jats:tex-math>$$\\:P=0.03$$<\/jats:tex-math>\n                      <\/jats:inline-formula>\n                      ) and subclonal kataegis (\n                      <jats:inline-formula>\n                        <jats:tex-math>$$\\:P=1.67\\times\\:{10}^{-3}$$<\/jats:tex-math>\n                      <\/jats:inline-formula>\n                      ) showed African specificity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We found kataegis-positivity to be associated with poor PCa presentation and prognosis, irrespective of patient ancestry. Kataegis-related genomic instability occurring early and late during African derived tumourigenesis, may partly explain the heightened tumour and clinical heterogeneity observed for patients of African ancestry.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13073-026-01647-5","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T12:59:02Z","timestamp":1777121942000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Single base focal hypermutation cooccurs with structural variation as an early event in advanced prostate tumourigenesis with ancestry specific independence: a multi-ancestral observational study"],"prefix":"10.1186","volume":"18","author":[{"given":"Jue","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avraam","family":"Tapinos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruotian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. S. Riana","family":"Bornman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip D.","family":"Stricker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingai B. A.","family":"Mutambirwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Wedge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weerachai","family":"Jaratlerdsiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa M.","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,25]]},"reference":[{"issue":"3","key":"1647_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"1647_CR2","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/cncr.34979","volume":"130","author":"KM Lee","year":"2024","unstructured":"Lee KM, et al. Association between prediagnostic prostate-specific antigen and prostate cancer probability in Black and non-Hispanic White men. Cancer. 2024;130(2):224\u201331.","journal-title":"Cancer"},{"issue":"1","key":"1647_CR3","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/MOU.0000000000000951","volume":"32","author":"SS Nair","year":"2022","unstructured":"Nair SS, et al. Why do African-American men face higher risks for lethal prostate cancer? Curr Opin Urol. 2022;32(1):96\u2013101.","journal-title":"Curr Opin Urol"},{"issue":"5","key":"1647_CR4","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.cell.2012.04.023","volume":"149","author":"S Nik-Zainal","year":"2012","unstructured":"Nik-Zainal S, et al. The life history of 21 breast cancers. Cell. 2012;149(5):994\u20131007.","journal-title":"Cell"},{"issue":"7793","key":"1647_CR5","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41586-020-1969-6","volume":"578","author":"LA Aaltonen","year":"2020","unstructured":"Aaltonen LA, et al. Pan-cancer analysis of whole genomes. Nature. 2020;578(7793):82\u201393.","journal-title":"Nature"},{"key":"1647_CR6","doi-asserted-by":"publisher","first-page":"e00534","DOI":"10.7554\/eLife.00534","volume":"2","author":"BJ Taylor","year":"2013","unstructured":"Taylor BJ, et al. DNA deaminases induce break-associated mutation showers with implication of APOBEC3B and 3A in breast cancer kataegis. elife. 2013;2:e00534.","journal-title":"elife"},{"issue":"1","key":"1647_CR7","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41523-024-00640-8","volume":"10","author":"S Veerla","year":"2024","unstructured":"Veerla S, Staaf J. Kataegis in clinical and molecular subgroups of primary breast cancer. npj Breast Cancer. 2024;10(1):32.","journal-title":"npj Breast Cancer"},{"issue":"8004","key":"1647_CR8","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41586-024-07054-3","volume":"627","author":"L Chen","year":"2024","unstructured":"Chen L, et al. Deep whole-genome analysis of 494 hepatocellular carcinomas. Nature. 2024;627(8004):586\u201393.","journal-title":"Nature"},{"issue":"7463","key":"1647_CR9","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature12477","volume":"500","author":"LB Alexandrov","year":"2013","unstructured":"Alexandrov LB, et al. Signatures of mutational processes in human cancer. Nature. 2013;500(7463):415\u201321.","journal-title":"Nature"},{"issue":"1","key":"1647_CR10","doi-asserted-by":"publisher","first-page":"6946","DOI":"10.1038\/s41467-021-27079-w","volume":"12","author":"N Ansari-Pour","year":"2021","unstructured":"Ansari-Pour N, et al. Whole-genome analysis of Nigerian patients with breast cancer reveals ethnic-driven somatic evolution and distinct genomic subtypes. Nat Commun. 2021;12(1):6946.","journal-title":"Nat Commun"},{"issue":"1","key":"1647_CR11","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12915-022-01316-0","volume":"20","author":"GM Jakobsdottir","year":"2022","unstructured":"Jakobsdottir GM, et al. APOBEC3 mutational signatures are associated with extensive and diverse genomic instability across multiple tumour types. BMC Biol. 2022;20(1):117.","journal-title":"BMC Biol"},{"issue":"3","key":"1647_CR12","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.celrep.2016.06.026","volume":"16","author":"M D\u2019Antonio","year":"2016","unstructured":"D\u2019Antonio M, et al. Kataegis expression signature in breast cancer is associated with late onset, better prognosis, and higher HER2 levels. Cell Rep. 2016;16(3):672\u201383.","journal-title":"Cell Rep"},{"issue":"9","key":"1647_CR13","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1038\/s41588-020-0667-5","volume":"52","author":"J Maciejowski","year":"2020","unstructured":"Maciejowski J, et al. APOBEC3-dependent kataegis and TREX1-driven chromothripsis during telomere crisis. Nat Genet. 2020;52(9):884\u201390.","journal-title":"Nat Genet"},{"issue":"7","key":"1647_CR14","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/j.cell.2015.11.054","volume":"163","author":"J Maciejowski","year":"2015","unstructured":"Maciejowski J, et al. Chromothripsis and kataegis induced by telomere crisis. Cell. 2015;163(7):1641\u201354.","journal-title":"Cell"},{"issue":"4","key":"1647_CR15","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/ng.3221","volume":"47","author":"CS Cooper","year":"2015","unstructured":"Cooper CS, et al. Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue. Nat Genet. 2015;47(4):367\u201372.","journal-title":"Nat Genet"},{"issue":"2","key":"1647_CR16","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1534\/genetics.114.164350","volume":"197","author":"A Raj","year":"2014","unstructured":"Raj A, Stephens M, Pritchard JK. fastSTRUCTURE: variational inference of population structure in large SNP data sets. Genetics. 2014;197(2):573\u201389.","journal-title":"Genetics"},{"key":"1647_CR17","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/s41586-022-05154-6","volume":"609","author":"W Jaratlerdsiri","year":"2022","unstructured":"Jaratlerdsiri W, et al. African-specific molecular taxonomy of prostate cancer. Nature. 2022;609:552\u20139.","journal-title":"Nature"},{"key":"1647_CR18","unstructured":"Patrick SM et al. Prostate cancer clinicopathological presentation in South-East Africa during the 2010 decade. JNCI: J Natl Cancer Inst, 2025: p. djaf117."},{"issue":"15","key":"1647_CR19","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.3390\/cancers17152481","volume":"17","author":"J Jiang","year":"2025","unstructured":"Jiang J, et al. Scaling for African Inclusion in High-Throughput Whole Cancer Genome Bioinformatic Workflows. Cancers. 2025;17(15):2481.","journal-title":"Cancers"},{"issue":"14","key":"1647_CR20","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Durbin R. Fast and accurate short read alignment with Burrows\u2013Wheeler transform. Bioinformatics. 2009;25(14):1754\u201360.","journal-title":"Bioinformatics"},{"issue":"17","key":"1647_CR21","doi-asserted-by":"publisher","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","volume":"34","author":"S Chen","year":"2018","unstructured":"Chen S, et al. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics. 2018;34(17):i884\u201390.","journal-title":"Bioinformatics"},{"issue":"17","key":"1647_CR22","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1093\/bioinformatics\/btu314","volume":"30","author":"GG Faust","year":"2014","unstructured":"Faust GG, Hall IM. SAMBLASTER: fast duplicate marking and structural variant read extraction. Bioinformatics. 2014;30(17):2503\u20135.","journal-title":"Bioinformatics"},{"issue":"5","key":"1647_CR23","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/ng.806","volume":"43","author":"MA DePristo","year":"2011","unstructured":"DePristo MA, et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet. 2011;43(5):491\u20138.","journal-title":"Nat Genet"},{"issue":"1","key":"1647_CR24","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s13059-021-02423-x","volume":"22","author":"DL Cameron","year":"2021","unstructured":"Cameron DL, et al. GRIDSS2: comprehensive characterisation of somatic structural variation using single breakend variants and structural variant phasing. Genome Biol. 2021;22(1):202.","journal-title":"Genome Biol"},{"issue":"8","key":"1647_CR25","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1093\/bioinformatics\/btv710","volume":"32","author":"X Chen","year":"2016","unstructured":"Chen X, et al. Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications. Bioinformatics. 2016;32(8):1220\u20132.","journal-title":"Bioinformatics"},{"issue":"1","key":"1647_CR26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13059-015-0602-8","volume":"16","author":"AG Deshwar","year":"2015","unstructured":"Deshwar AG, et al. PhyloWGS: Reconstructing subclonal composition and evolution from whole-genome sequencing of tumors. Genome Biol. 2015;16(1):35.","journal-title":"Genome Biol"},{"issue":"11","key":"1647_CR27","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1101\/gr.180281.114","volume":"24","author":"G Ha","year":"2014","unstructured":"Ha G, et al. TITAN: inference of copy number architectures in clonal cell populations from tumor whole-genome sequence data. Genome Res. 2014;24(11):1881\u201393.","journal-title":"Genome Res"},{"issue":"7793","key":"1647_CR28","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s41586-019-1907-7","volume":"578","author":"M Gerstung","year":"2020","unstructured":"Gerstung M, et al. The evolutionary history of 2,658 cancers. Nature. 2020;578(7793):122\u20138.","journal-title":"Nature"},{"issue":"4","key":"1647_CR29","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/s41587-019-0055-9","volume":"37","author":"J Zhang","year":"2019","unstructured":"Zhang J, et al. The international cancer genome consortium data portal. Nat Biotechnol. 2019;37(4):367\u20139.","journal-title":"Nat Biotechnol"},{"issue":"7637","key":"1647_CR30","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nature20788","volume":"541","author":"M Fraser","year":"2017","unstructured":"Fraser M, et al. Genomic hallmarks of localized, non-indolent prostate cancer. Nature. 2017;541(7637):359\u201364.","journal-title":"Nature"},{"issue":"7801","key":"1647_CR31","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41586-020-2135-x","volume":"580","author":"J Li","year":"2020","unstructured":"Li J, et al. A genomic and epigenomic atlas of prostate cancer in Asian populations. Nature. 2020;580(7801):93\u20139.","journal-title":"Nature"},{"issue":"1","key":"1647_CR32","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1186\/s12864-021-07696-x","volume":"22","author":"X Lin","year":"2021","unstructured":"Lin X, et al. kataegis: an R package for identification and visualization of the genomic localized hypermutation regions using high-throughput sequencing. BMC Genomics. 2021;22(1):440.","journal-title":"BMC Genomics"},{"key":"1647_CR33","unstructured":"Team RC. R: A language and environment for statistical computing. R Foundation for Statistical Computing. No Title); 2013."},{"key":"1647_CR34","unstructured":"Kassambara A. ggpubr:\u2018ggplot2\u2019based publication ready plots. R package version, 2018: p. 2."},{"issue":"5","key":"1647_CR35","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41588-018-0078-z","volume":"50","author":"J Armenia","year":"2018","unstructured":"Armenia J, et al. The long tail of oncogenic drivers in prostate cancer. Nat Genet. 2018;50(5):645\u201351.","journal-title":"Nat Genet"},{"key":"1647_CR36","doi-asserted-by":"crossref","unstructured":"Ding L et al. The roles of cyclin-dependent kinases in cell-cycle progression and therapeutic strategies in human breast cancer. International journal of molecular sciences, 2020. 21(6): p. 1960.","DOI":"10.3390\/ijms21061960"},{"issue":"10","key":"1647_CR37","first-page":"28","volume":"128","author":"TM Therneau","year":"2015","unstructured":"Therneau TM, Lumley T. Package \u2018survival\u2019. R Top Doc. 2015;128(10):28\u201333.","journal-title":"R Top Doc"},{"key":"1647_CR38","first-page":"p2021","volume":"9","author":"A Kassambara","year":"2021","unstructured":"Kassambara A, et al. survminer: Drawing Survival Curves using \u2018ggplot2\u2019. R package version 0 4. 2021;9:p2021.","journal-title":"R package version 0 4"},{"key":"1647_CR39","doi-asserted-by":"crossref","unstructured":"Islam SA et al. Uncovering novel mutational signatures by de novo extraction with SigProfilerExtractor. Cell genomics, 2022. 2(11).","DOI":"10.1016\/j.xgen.2022.100179"},{"issue":"2","key":"1647_CR40","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/bib\/bbs038","volume":"14","author":"RM Kuhn","year":"2013","unstructured":"Kuhn RM, Haussler D, Kent WJ. The UCSC genome browser and associated tools. Brief Bioinform. 2013;14(2):144\u201361.","journal-title":"Brief Bioinform"},{"key":"1647_CR41","doi-asserted-by":"crossref","unstructured":"Everall A et al. Comprehensive repertoire of the chromosomal alteration and mutational signatures across 16 cancer types from 10,983 cancer patients. medRxiv, 2023: p. 2023.06. 07.23290970.","DOI":"10.1101\/2023.06.07.23290970"},{"issue":"9","key":"1647_CR42","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/ng.3378","volume":"47","author":"K Chan","year":"2015","unstructured":"Chan K, et al. An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancers. Nat Genet. 2015;47(9):1067\u201372.","journal-title":"Nat Genet"},{"issue":"9","key":"1647_CR43","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/ng.2702","volume":"45","author":"SA Roberts","year":"2013","unstructured":"Roberts SA, et al. An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. Nat Genet. 2013;45(9):970\u20136.","journal-title":"Nat Genet"},{"issue":"1","key":"1647_CR44","doi-asserted-by":"publisher","first-page":"4711","DOI":"10.1038\/s41467-025-59923-8","volume":"16","author":"T Zhang","year":"2025","unstructured":"Zhang T, et al. APOBEC affects tumor evolution and age at onset of lung cancer in smokers. Nat Commun. 2025;16(1):4711.","journal-title":"Nat Commun"},{"key":"1647_CR45","doi-asserted-by":"crossref","unstructured":"Law EK et al. APOBEC3A catalyzes mutation and drives carcinogenesis in vivo. J Exp Med, 2020. 217(12).","DOI":"10.1084\/jem.20200261"},{"issue":"1","key":"1647_CR46","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12916-021-02230-y","volume":"20","author":"SWD Merriel","year":"2022","unstructured":"Merriel SWD, et al. Systematic review and meta-analysis of the diagnostic accuracy of prostate-specific antigen (PSA) for the detection of prostate cancer in symptomatic patients. BMC Med. 2022;20(1):54.","journal-title":"BMC Med"},{"issue":"10","key":"1647_CR47","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.3390\/cancers13102453","volume":"13","author":"D Milonas","year":"2021","unstructured":"Milonas D, et al. The significance of prostate specific antigen persistence in prostate cancer risk groups on long-term oncological outcomes. Cancers. 2021;13(10):2453.","journal-title":"Cancers"},{"issue":"6","key":"1647_CR48","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.ccell.2018.10.016","volume":"34","author":"C Gerhauser","year":"2018","unstructured":"Gerhauser C, et al. Molecular evolution of early-onset prostate cancer identifies molecular risk markers and clinical trajectories. Cancer Cell. 2018;34(6):996\u20131011. e8.","journal-title":"Cancer Cell"},{"issue":"5","key":"1647_CR49","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/ng.2955","volume":"46","author":"S Nik-Zainal","year":"2014","unstructured":"Nik-Zainal S, et al. Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer. Nat Genet. 2014;46(5):487\u201391.","journal-title":"Nat Genet"},{"issue":"11","key":"1647_CR50","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1038\/ng.3670","volume":"48","author":"CD Middlebrooks","year":"2016","unstructured":"Middlebrooks CD, et al. Association of germline variants in the APOBEC3 region with cancer risk and enrichment with APOBEC-signature mutations in tumors. Nat Genet. 2016;48(11):1330\u20138.","journal-title":"Nat Genet"},{"issue":"1","key":"1647_CR51","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41392-020-0134-x","volume":"5","author":"J Fares","year":"2020","unstructured":"Fares J, et al. Molecular principles of metastasis: a hallmark of cancer revisited. Signal Transduct Target Therapy. 2020;5(1):28.","journal-title":"Signal Transduct Target Therapy"},{"issue":"1","key":"1647_CR52","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/s42003-022-03796-w","volume":"5","author":"G Perron","year":"2022","unstructured":"Perron G, et al. Pan-cancer analysis of mRNA stability for decoding tumour post-transcriptional programs. Commun Biology. 2022;5(1):851.","journal-title":"Commun Biology"},{"issue":"6","key":"1647_CR53","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1158\/1078-0432.CCR-18-1943","volume":"25","author":"B De Laere","year":"2019","unstructured":"De Laere B, et al. TP53 outperforms other androgen receptor biomarkers to predict abiraterone or enzalutamide outcome in metastatic castration-resistant prostate cancer. Clin Cancer Res. 2019;25(6):1766\u201373.","journal-title":"Clin Cancer Res"},{"issue":"10","key":"1647_CR54","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.3390\/ijms20102587","volume":"20","author":"SK Wong","year":"2019","unstructured":"Wong SK, et al. Prostate cancer and bone metastases: the underlying mechanisms. Int J Mol Sci. 2019;20(10):2587.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1647_CR55","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.1371\/journal.pgen.0030063","volume":"3","author":"JM Kidd","year":"2007","unstructured":"Kidd JM, et al. Population stratification of a common APOBEC gene deletion polymorphism. PLoS Genet. 2007;3(4):e63.","journal-title":"PLoS Genet"},{"key":"1647_CR56","doi-asserted-by":"publisher","first-page":"102905","DOI":"10.1016\/j.dnarep.2020.102905","volume":"94","author":"M Petljak","year":"2020","unstructured":"Petljak M, Maciejowski J. Molecular origins of APOBEC-associated mutations in cancer. DNA Repair (Amst). 2020;94:102905.","journal-title":"DNA Repair (Amst)"},{"key":"1647_CR57","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1146\/annurev-genet-072920-035840","volume":"56","author":"TM Mertz","year":"2022","unstructured":"Mertz TM, et al. APOBEC-induced mutagenesis in cancer. Annu Rev Genet. 2022;56:229\u201352.","journal-title":"Annu Rev Genet"},{"issue":"1","key":"1647_CR58","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s10555-024-10168-9","volume":"43","author":"M Ashrafizadeh","year":"2024","unstructured":"Ashrafizadeh M, et al. Molecular panorama of therapy resistance in prostate cancer: a pre-clinical and bioinformatics analysis for clinical translation. Cancer Metastasis Rev. 2024;43(1):229\u201360.","journal-title":"Cancer Metastasis Rev"},{"issue":"18","key":"1647_CR59","doi-asserted-by":"publisher","first-page":"9666","DOI":"10.1093\/nar\/gkz651","volume":"47","author":"R Elango","year":"2019","unstructured":"Elango R, et al. Repair of base damage within break-induced replication intermediates promotes kataegis associated with chromosome rearrangements. Nucleic Acids Res. 2019;47(18):9666\u201384.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"1647_CR60","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1016\/j.celrep.2014.04.053","volume":"7","author":"CJ Sakofsky","year":"2014","unstructured":"Sakofsky CJ, et al. Break-induced replication is a source of mutation clusters underlying kataegis. Cell Rep. 2014;7(5):1640\u20138.","journal-title":"Cell Rep"},{"key":"1647_CR61","doi-asserted-by":"publisher","first-page":"102700","DOI":"10.1016\/j.dnarep.2019.102700","volume":"83","author":"AM Green","year":"2019","unstructured":"Green AM, Weitzman MD. The spectrum of APOBEC3 activity: From anti-viral agents to anti-cancer opportunities. DNA Repair. 2019;83:102700.","journal-title":"DNA Repair"},{"issue":"2","key":"1647_CR62","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3390\/genes6020267","volume":"6","author":"C Gelot","year":"2015","unstructured":"Gelot C, Magdalou I, Lopez BS. Replication stress in Mammalian cells and its consequences for mitosis. Genes. 2015;6(2):267\u201398.","journal-title":"Genes"},{"issue":"1","key":"1647_CR63","doi-asserted-by":"publisher","first-page":"7706","DOI":"10.1038\/s41598-024-57566-1","volume":"14","author":"R Huang","year":"2024","unstructured":"Huang R, et al. The impact of telomere length on prostate cancer aggressiveness, genomic instability and health disparities. Sci Rep. 2024;14(1):7706.","journal-title":"Sci Rep"},{"issue":"10","key":"1647_CR64","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1038\/s41588-023-01504-w","volume":"55","author":"JL McCann","year":"2023","unstructured":"McCann JL, et al. APOBEC3B regulates R-loops and promotes transcription-associated mutagenesis in cancer. Nat Genet. 2023;55(10):1721\u201334.","journal-title":"Nat Genet"},{"issue":"2","key":"1647_CR65","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1101\/gr.197046.115","volume":"26","author":"VB Seplyarskiy","year":"2016","unstructured":"Seplyarskiy VB, et al. APOBEC-induced mutations in human cancers are strongly enriched on the lagging DNA strand during replication. Genome Res. 2016;26(2):174\u201382.","journal-title":"Genome Res"},{"issue":"12","key":"1647_CR66","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1016\/j.molcel.2022.05.004","volume":"82","author":"S Saxena","year":"2022","unstructured":"Saxena S, Zou L. Hallmarks of DNA replication stress. Mol Cell. 2022;82(12):2298\u2013314.","journal-title":"Mol Cell"},{"key":"1647_CR67","doi-asserted-by":"publisher","unstructured":"Hayes VM, [Jiang JW, Gong J, Patrick T, Willet SM, Chew C, Lyons T, Haynes RJ, Pasqualim AM, Louw G, Kench M, Campbell JG, Horvath R, Chan LG, Wedge EKF, Sadsad DC, Brum R, Mutambirwa IS, Stricker SBA, Bornman PD, MSR]. African-specific molecular taxonomy of prostate cancer. Datasets; 2022. https:\/\/doi.org\/10.1038\/s41586-022-05154-6. The European Genome-phenome Archive.","DOI":"10.1038\/s41586-022-05154-6"},{"key":"1647_CR68","doi-asserted-by":"publisher","unstructured":"Boutros PC, [Sabelnykova FM, Yamaguchi VY, Heisler TN, Livingstone LE, Huang J, Shiah V, Yousif YJ, Lin F, Masella X, Fox AP, Xie NS, Prokopec M, Berlin SD, Lalonde A, Ahmed E, Trudel M, Luo D, Beck X, Meng TA, Zhang A, D\u2019Costa J, Denroche A, Kong RE, Espiritu H, Chua SM, Wong ML, Chong A, Sam T, Johns M, Timms J, Buchner L, Orain NB, Picard M, Hovington V, Murison H, Kron A, Harding K, P\u2019ng NJ, Houlahan C, Chu KE, Lo KC, Nguyen B, Li F, Sun CH, de Borja RX, Cooper R, Hopkins CI, Govind JF, Fung SK, Waggott C, Green D, Haider J, Chan-Seng-Yue S, Jung MA, Wang E, Bergeron Z, Dal Pra A, Lacombe A, Collins L, Sahinalp CC, Lupien C, Fleshner M, He NE, Fradet HH, Tetu Y, van der Kwast B, McPherson T. JD, Bristow RG], Genomic hallmarks of localized, non-indolent prostate cancer. Dataset. International Cancer Genome Consortium (ICGC) Data Portal https:\/\/doi.org\/10.1038\/nature20788 (2017).","DOI":"10.1038\/nature20788"},{"key":"1647_CR69","doi-asserted-by":"publisher","unstructured":"Sun Y, [Xu LJ, Lee C, Ren HJ, Zi S, Zhang X, Wang Z, Yu H, Yang Y, Gao C, Hou X, Wang J, Yang L, Yang B, Ye Q, Zhou H, Lu T, Wang X, Qu Y, Yang M, Zhang Q, Shah W, Pehrsson NM, Wang EC, Wang S, Jiang Z, Zhu J, Chen Y, Chen R, Zhu H, Lian F, Li B, Zhang X, Wang Y, Wang C, Xiao Y, Jiang G, Yang J, Liang Y, Hou C, Han J, Chen C, Jiang M, Zhang N, Wu D, Yang S, Wang J, Chen T, Cai Y, Yang J, Xu W, Wang J, Gao S, Wang X. T], A genomic and epigenomic atlas of prostate cancer in Asian populations. Datasets. Genome Sequence Archive for Human; 2020. https:\/\/doi.org\/10.1038\/s41586-020-2135-x.","DOI":"10.1038\/s41586-020-2135-x"}],"container-title":["Genome Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13073-026-01647-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-026-01647-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-026-01647-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:02:48Z","timestamp":1781827368000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13073-026-01647-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,25]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1647"],"URL":"https:\/\/doi.org\/10.1186\/s13073-026-01647-5","relation":{},"ISSN":["1756-994X"],"issn-type":[{"value":"1756-994X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,25]]},"assertion":[{"value":"15 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Conforming to the principles of the Helsinki Declaration, South African patients were recruited at diagnosis as part of the Southern African Prostate Cancer Study (SAPCS) with approval granted by the University of Pretoria Faculty of Health Human Research Ethics Committee (HRECs, with US Federal wide assurance FWA00002567 and IRB00002235 IORG0001762; #43\/2010) and in Australia at surgery as part of the Garvan\/St Vincent\u2019s Prostate Cancer Biobank with approval granted by the St Vincent\u2019s HREC (#SVH\/12\/231). All patients provided written consent to participate. While consumer representatives are involved at all stages from study design to reporting, no patients were directly involved in design, conduct or dissemination of research. Inter-institutional Collaborative Research Agreement (CRA) and\/or Material and Data Sharing Agreements (MTA\/DSA) between the University of Pretoria, Garvan Institute of Medical Research and University of Sydney, allowed for material and data sharing, including for local researcher inclusion from study design, funding, execution, interpretation to publication. Materials were exported out of South Africa though a Republic of South Africa Department of Health Export Permit (National Health Act 2003; J1\/2\/4\/2 #1\/12). Further study approval for multi-omic interrogations was approved by the St. Vincent\u2019s HREC (#SVH\/15\/227), with additional IRB review and approval granted by the Human Research Protection Office of the US Army Medical Research and Development Command E02371 (TARGET Africa) and E03280 (HEROIC PCaPH Africa1K).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All data used in this study has been previously published, which included patient consent for deidentified publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Hayes is a Member of Active Surveillance Movember Committee.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"87"}}